Considerable efforts have been made over the years to resolve the key issues of stability and delivery of RNA-based therapeutics.

The Marriage of RNA and Mass Spectrometry

Variability instills consistency in advanced therapy medicinal products.

Potency Assays for Novel Complex Modalities

Biologic drug development requires relevant bioassays to measure and help predict cellular response.

Feliza Mirasol is the science editor for 

Analytical characterization of biosimilars plays a crucial role in a successful path to regulatory approval.

Grant Playter is the Assistant Editor for 

ProBioGen’s Lenti.RiGHT is a lentivirus production platform for use in gene transfer applications.

Editor of Pharmaceutical Technology Europe

Waters Corporation expected to boost growth in bioanalytical characterization for new modalities with acquisition of Wyatt Technology.

Webinar Date/Time: Wed, Jun 14, 2023 10:00 AM EDT


Webinar Date/Time: Thu, Jun 1, 2023 11:00 AM EDT


Avoiding missteps in data integrity is contingent on the development of a holistic data integrity approach.

Webinar Date/Time: Tue, May 16, 2023 11:00 AM EDT


Preclinical studies specifically benefit from the “smart” drug development trend through deeper data access and analysis.

Webinar Dates/Times:
Thursday, June 29, 2023 at 17:00 CEST | 11:00 EDT | 08:00 PDT